2017 annual financial data
Emergent BioSolutions 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was 37.11%.
Operating income was 124,300,000 USD and net income was 82,600,000 USD.
Operating cash flow was 208,139,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 560,900,000 USD
- Operating income
- 124,300,000 USD
- Net income
- 82,600,000 USD
- Operating cash flow
- 208,139,000 USD